Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Balance Sheet

MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
EQUITY AND LIABILITIES
Share Capital ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity - Authorised ₹228 Cr₹228 Cr₹209 Cr₹41 Cr₹41 Cr
    Equity - Issued ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Paid Up ₹41 Cr₹41 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹48 Cr₹44 Cr₹23 Cr₹0.06 Cr-
Total Reserves ₹16,211 Cr₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr
    Securities Premium ₹3,043 Cr₹3,008 Cr₹42 Cr₹42 Cr₹42 Cr
    Capital Reserves ₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr
    Profit & Loss Account Balance ₹13,804 Cr₹11,907 Cr₹9,919 Cr₹8,012 Cr₹6,735 Cr
    General Reserves ₹238 Cr₹238 Cr₹238 Cr₹238 Cr₹238 Cr
    Other Reserves ₹35 Cr₹3.84 Cr₹10 Cr₹12 Cr₹9.11 Cr
Reserve excluding Revaluation Reserve ₹16,211 Cr₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr
Revaluation reserve -----
Shareholder's Funds ₹16,300 Cr₹14,332 Cr₹9,363 Cr₹7,435 Cr₹6,155 Cr
Minority Interest ₹261 Cr₹236 Cr₹213 Cr₹188 Cr₹161 Cr
Long-Term Borrowings -----
Secured Loans ₹2,483 Cr₹5,078 Cr₹25 Cr₹23 Cr₹49 Cr
    Non Convertible Debentures ₹4,971 Cr₹4,943 Cr---
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks ₹74 Cr₹396 Cr₹43 Cr₹45 Cr₹67 Cr
    Term Loans - Institutions -----
    Other Secured ₹-2,561 Cr₹-261 Cr₹-19 Cr₹-22 Cr₹-18 Cr
Unsecured Loans ₹339 Cr₹448 Cr--₹0.25 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks -₹131 Cr---
    Loans - Govt. -----
    Loans - Others ₹339 Cr₹317 Cr--₹0.25 Cr
    Other Unsecured Loan -----
Deferred Tax Assets / Liabilities ₹1,515 Cr₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr
    Deferred Tax Assets ₹735 Cr₹728 Cr₹454 Cr₹315 Cr₹228 Cr
    Deferred Tax Liability ₹2,250 Cr₹2,432 Cr₹463 Cr₹362 Cr₹244 Cr
Other Long Term Liabilities ₹101 Cr₹34 Cr₹31 Cr₹31 Cr₹23 Cr
Long Term Trade Payables -----
Long Term Provisions ₹249 Cr₹155 Cr₹123 Cr₹98 Cr₹80 Cr
Total Non-Current Liabilities ₹4,687 Cr₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr
Current Liabilities -----
Trade Payables ₹1,341 Cr₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr
    Sundry Creditors ₹1,341 Cr₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹3,702 Cr₹1,335 Cr₹756 Cr₹386 Cr₹473 Cr
    Bank Overdraft / Short term credit ----₹11 Cr
    Advances received from customers ₹28 Cr₹33 Cr₹27 Cr₹26 Cr₹17 Cr
    Interest Accrued But Not Due ₹183 Cr₹183 Cr---
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹3,491 Cr₹1,120 Cr₹728 Cr₹360 Cr₹446 Cr
Short Term Borrowings ₹639 Cr₹2,513 Cr₹151 Cr₹115 Cr₹795 Cr
    Secured ST Loans repayable on Demands ₹538 Cr₹505 Cr₹151 Cr₹115 Cr₹731 Cr
    Working Capital Loans- Sec ₹538 Cr₹497 Cr₹151 Cr₹115 Cr₹731 Cr
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹-437 Cr₹1,512 Cr₹-151 Cr₹-115 Cr₹-668 Cr
Short Term Provisions ₹825 Cr₹682 Cr₹436 Cr₹354 Cr₹280 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹11 Cr₹18 Cr₹8.38 Cr₹46 Cr₹15 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions ₹814 Cr₹664 Cr₹427 Cr₹308 Cr₹265 Cr
Total Current Liabilities ₹6,507 Cr₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr
Total Liabilities ₹27,755 Cr₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr
ASSETS
Gross Block ₹21,377 Cr₹20,917 Cr₹5,910 Cr₹5,233 Cr₹4,247 Cr
Less: Accumulated Depreciation ₹2,756 Cr₹1,912 Cr₹1,370 Cr₹988 Cr₹664 Cr
Less: Impairment of Assets -----
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹655 Cr₹306 Cr₹207 Cr₹493 Cr₹670 Cr
Non Current Investments ₹448 Cr₹351 Cr₹310 Cr₹271 Cr₹235 Cr
Long Term Investment ₹448 Cr₹351 Cr₹310 Cr₹271 Cr₹235 Cr
    Quoted -----
    Unquoted ₹509 Cr₹411 Cr₹364 Cr₹325 Cr₹285 Cr
Long Term Loans & Advances ₹555 Cr₹293 Cr₹164 Cr₹188 Cr₹164 Cr
Other Non Current Assets ₹50 Cr₹189 Cr₹14 Cr₹99 Cr₹13 Cr
Total Non-Current Assets ₹20,801 Cr₹20,663 Cr₹5,315 Cr₹5,358 Cr₹4,702 Cr
Current Assets Loans & Advances -----
Currents Investments ₹1,537 Cr₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr
    Quoted ₹1,537 Cr₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr
    Unquoted -----
Inventories ₹2,144 Cr₹2,094 Cr₹1,553 Cr₹1,498 Cr₹1,760 Cr
    Raw Materials ₹629 Cr₹552 Cr₹409 Cr₹414 Cr₹399 Cr
    Work-in Progress ₹223 Cr₹186 Cr₹100 Cr₹86 Cr₹94 Cr
    Finished Goods ₹288 Cr₹300 Cr₹263 Cr₹285 Cr₹310 Cr
    Packing Materials -----
    Stores  and Spare ₹55 Cr₹46 Cr₹44 Cr₹35 Cr₹24 Cr
    Other Inventory ₹950 Cr₹1,010 Cr₹738 Cr₹678 Cr₹934 Cr
Sundry Debtors ₹1,730 Cr₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr
    Debtors more than Six months ₹75 Cr₹68 Cr₹44 Cr₹21 Cr₹15 Cr
    Debtors Others ₹1,716 Cr₹1,531 Cr₹832 Cr₹575 Cr₹385 Cr
Cash and Bank ₹483 Cr₹555 Cr₹708 Cr₹453 Cr₹406 Cr
    Cash in hand ₹0.68 Cr₹0.55 Cr₹0.74 Cr₹0.46 Cr₹0.25 Cr
    Balances at Bank ₹482 Cr₹554 Cr₹707 Cr₹453 Cr₹403 Cr
    Other cash and bank balances ----₹2.29 Cr
Other Current Assets ₹101 Cr₹97 Cr₹104 Cr₹64 Cr₹171 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹52 Cr₹61 Cr₹60 Cr₹33 Cr₹136 Cr
    Other current_assets ₹49 Cr₹36 Cr₹44 Cr₹31 Cr₹35 Cr
Short Term Loans and Advances ₹957 Cr₹1,011 Cr₹1,093 Cr₹657 Cr₹804 Cr
    Advances recoverable in cash or in kind ₹124 Cr₹91 Cr₹42 Cr₹77 Cr₹73 Cr
    Advance income tax and TDS -----
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹833 Cr₹919 Cr₹1,052 Cr₹580 Cr₹731 Cr
Total Current Assets ₹6,952 Cr₹6,986 Cr₹6,566 Cr₹4,325 Cr₹4,404 Cr
Net Current Assets (Including Current Investments) ₹444 Cr₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹27,755 Cr₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr
Contingent Liabilities ₹925 Cr₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr
Total Debt ₹6,022 Cr₹8,300 Cr₹196 Cr₹163 Cr₹868 Cr
Book Value 393.72346.31233.15185.61153.65
Adjusted Book Value 393.72346.31233.15185.61153.65

Compare Balance Sheet of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,108.5 Cr 0.8% 8% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.8% 8.3% 17.1% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7.1% 9% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,316.0 Cr 2% 12.1% 49.6% Stock Analytics
CIPLA ₹115,477.0 Cr -0.7% 4.1% -3.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -1.7% -4.2% -3.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.8%

8%

0.8%

SENSEX

0.6%

1.2%

-7.8%


You may also like the below Video Courses